Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Operating income3 4 5 6 7 -$112.8M in 2025+408% since 2020 -$150.0M -$100.0M -$50.0M 0 2020: -$22.2M -$22.2M 2020 2021: -$35.2M -$35.2M 2021 +59% 2022: -$60.3M -$60.3M 2022 +71% 2023: -$85.0M -$85.0M 2023 +41% 2024: -$96.1M -$96.1M 2024 +13% 2025: -$112.8M -$112.8M 2025 +17% Net income3 4 5 6 7 -$106.2M in 2025+378% since 2020 -$150.0M -$100.0M -$50.0M 0 2020: -$22.2M -$22.2M 2020 2021: -$35.3M -$35.3M 2021 +59% 2022: -$58.8M -$58.8M 2022 +67% 2023: -$76.4M -$76.4M 2023 +30% 2024: -$86.9M -$86.9M 2024 +14% 2025: -$106.2M -$106.2M 2025 +22% Operating income8 9 -$48.1M in Q2 FY2026+38% since Q1 FY2026 -$60.0M -$40.0M -$20.0M 0 Q1 FY2026: -$34.9M -$34.9M Q1 FY2026 Q2 FY2026: -$48.1M -$48.1M Q2 FY2026 +38% Net income8 9 -$45.6M in Q2 FY2026+35% since Q1 FY2026 -$60.0M -$40.0M -$20.0M 0 Q1 FY2026: -$33.7M -$33.7M Q1 FY2026 Q2 FY2026: -$33.7M -$33.7M Q2 FY2026 +0% Q2 FY2026: -$45.6M -$45.6M Q2 FY2026 +35% Fiscal year 2019 2020 2021 2022 2023 2024 2025 2026 Research and development $18.0M3 $25.2M4 $42.2M5 $65.2M6 $73.3M7 $90.3M7 Operating income -$22.2M3 -$35.2M4 -$60.3M5 -$85.0M6 -$96.1M7 -$112.8M7 Income tax $03 $04 $05 $137.0K6 $112.0K7 $108.0K7 Net income -$22.2M3 -$35.3M4 -$58.8M5 -$76.4M6 -$86.9M7 -$106.2M7 Earnings per share -$8.954 -$1.965 -$1.936 -$1.757 -$1.767 Earnings per share (diluted) -$8.954 -$1.965 -$1.936 -$1.757 -$1.767
Total assets3 4 5 6 7 $169.4M in 2025+667% since 2020 0 $100.0M $200.0M $300.0M 2020: $22.1M $22.1M 2020 2021: $160.0M $160.0M 2021 +624% 2022: $223.9M $223.9M 2022 +40% 2023: $255.1M $255.1M 2023 +14% 2024: $182.5M $182.5M 2024 −28% 2025: $169.4M $169.4M 2025 −7% Total liabilities3 4 5 6 7 $32.5M in 2025+1086% since 2020 0 $10.0M $20.0M $30.0M $40.0M 2020: $2.7M $2.7M 2020 2021: $7.7M $7.7M 2021 +181% 2022: $28.4M $28.4M 2022 +267% 2023: $29.2M $29.2M 2023 +3% 2024: $30.5M $30.5M 2024 +4% 2025: $32.5M $32.5M 2025 +6% Shareholders’ equity3 4 5 6 7 $136.9M in 2025-$200.0M -$100.0M 0 $100.0M $200.0M $300.0M 2019: -$87.4M -$87.4M 2019 2020: -$108.7M -$108.7M 2020 +24% 2021: $152.3M $152.3M 2021 2022: $195.6M $195.6M 2022 +28% 2023: $225.8M $225.8M 2023 +15% 2024: $152.0M $152.0M 2024 −33% 2025: $136.9M $136.9M 2025 −10% Cash3 4 5 6 7 $59.5M in 2025+242% since 2020 0 $50.0M $100.0M $150.0M 2020: $17.4M $17.4M 2020 2021: $149.1M $149.1M 2021 +757% 2022: $121.6M $121.6M 2022 −18% 2023: $41.1M $41.1M 2023 −66% 2024: $31.7M $31.7M 2024 −23% 2025: $59.5M $59.5M 2025 +88% Total assets8 9 $348.1M in Q2 FY2026+105% since Q1 FY2025 0 $100.0M $200.0M $300.0M $400.0M Q1 FY2025: $169.4M $169.4M Q1 FY2025 Q2 FY2025: $169.4M $169.4M Q2 FY2025 +0% Q1 FY2026: $137.7M $137.7M Q1 FY2026 −19% Q2 FY2026: $348.1M $348.1M Q2 FY2026 +153% Total liabilities8 9 $32.9M in Q2 FY2026+1% since Q1 FY2025 0 $10.0M $20.0M $30.0M $40.0M Q1 FY2025: $32.5M $32.5M Q1 FY2025 Q2 FY2025: $32.5M $32.5M Q2 FY2025 +0% Q1 FY2026: $30.4M $30.4M Q1 FY2026 −6% Q2 FY2026: $32.9M $32.9M Q2 FY2026 +8% Shareholders’ equity8 9 $315.3M in Q2 FY2026+130% since Q1 FY2025 0 $100.0M $200.0M $300.0M $400.0M Q1 FY2025: $136.9M $136.9M Q1 FY2025 Q2 FY2025: $136.9M $136.9M Q2 FY2025 +0% Q1 FY2026: $107.2M $107.2M Q1 FY2026 −22% Q2 FY2026: $107.2M $107.2M Q2 FY2026 +0% Q2 FY2026: $315.3M $315.3M Q2 FY2026 +194% Cash8 9 $67.8M in Q2 FY2026+14% since Q1 FY2025 0 $25.0M $50.0M $75.0M $100.0M Q1 FY2025: $59.5M $59.5M Q1 FY2025 Q2 FY2025: $59.5M $59.5M Q2 FY2025 +0% Q1 FY2026: $84.8M $84.8M Q1 FY2026 +42% Q2 FY2026: $67.8M $67.8M Q2 FY2026 −20% Fiscal year 2019 2020 2021 2022 2023 2024 2025 2026 Cash $17.4M3 $149.1M4 $121.6M5 $41.1M6 $31.7M7 $59.5M7 Current assets $18.5M3 $153.7M4 $196.7M5 $231.8M6 $160.6M7 $149.7M7 Total assets $22.1M3 $160.0M4 $223.9M5 $255.1M6 $182.5M7 $169.4M7 Current liabilities $2.7M3 $7.4M4 $10.5M5 $12.4M6 $14.9M7 $18.4M7 Total liabilities $2.7M3 $7.7M4 $28.4M5 $29.2M6 $30.5M7 $32.5M7 Shareholders’ equity -$87.4M3 -$108.7M4 $152.3M5 $195.6M6 $225.8M7 $152.0M7 $136.9M7 Shares outstanding 381.1K shares3 29.2M shares4 37.8M shares5 49.4M shares6 50.0M shares7 63.6M shares7 64.2M shares7
Cash from operations3 4 5 6 7 -$84.7M in 2025+248% since 2020 -$100.0M -$75.0M -$50.0M -$25.0M 0 2020: -$24.3M -$24.3M 2020 2021: -$32.4M -$32.4M 2021 +33% 2022: -$54.6M -$54.6M 2022 +68% 2023: -$63.8M -$63.8M 2023 +17% 2024: -$79.8M -$79.8M 2024 +25% 2025: -$84.7M -$84.7M 2025 +6% Capital spending3 4 5 6 7 $447.0K in 2025−42% since 2020 0 $1.0M $2.0M $3.0M 2020: $771.0K $771.0K 2020 2021: $2.1M $2.1M 2021 +176% 2022: $1.1M $1.1M 2022 −49% 2023: $709.0K $709.0K 2023 −35% 2024: $1.3M $1.3M 2024 +77% 2025: $447.0K $447.0K 2025 −64% Free cash flow3 4 5 6 7 -$85.2M in 2025+240% since 2020 -$100.0M -$75.0M -$50.0M -$25.0M 0 2020: -$25.1M -$25.1M 2020 2021: -$34.5M -$34.5M 2021 +38% 2022: -$55.7M -$55.7M 2022 +61% 2023: -$64.6M -$64.6M 2023 +16% 2024: -$81.1M -$81.1M 2024 +26% 2025: -$85.2M -$85.2M 2025 +5% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2019 2020 2021 2022 2023 2024 2025 2026 Cash from operations -$24.3M3 -$32.4M4 -$54.6M5 -$63.8M6 -$79.8M7 -$84.7M7 Capital spending $771.0K3 $2.1M4 $1.1M5 $709.0K6 $1.3M7 $447.0K7 Free cash flow -$25.1M -$34.5M -$55.7M -$64.6M -$81.1M -$85.2M
Compare Aura Biosciences, Inc. with another company
Recent filings
Oct 1, 2026 SCHEDULE 13G Sep 1, 2026 S-8 Sep 1, 2026 4 Sep 1, 2026 4 Sep 1, 2026 4 Sep 1, 2026 4 Sep 1, 2026 4 Aug 20, 2026 EFFECT Aug 14, 2026 SCHEDULE 13G Aug 14, 2026 SCHEDULE 13G/A Aug 12, 2026 SCHEDULE 13G/A Aug 12, 2026 3 Aug 12, 2026 3 Aug 12, 2026 3 Aug 11, 2026 8-K Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
